Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Desensitization of human platelets by platelet activating factor.

C M Chesney, D D Pifer, K M Huch

    Biochemical and Biophysical Research Communications
    |February 28, 1985
    PubMed
    Summary

    Human platelets show reduced responsiveness to platelet-activating factor (PAF) at higher temperatures and can be desensitized. This desensitization involves a decreased affinity for PAF, not a loss of binding sites.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cardiovascular effects of vasopressin following V(1) receptor blockade compared to effects of nitroglycerin.

    American journal of physiology. Regulatory, integrative and comparative physiology·2001
    Same author

    Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).

    American heart journal·2000
    Same author

    Risk factors for development of proteinuria in chronic spinal cord injury.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1999
    Same author

    Hemodynamic response to vasopressin in dehydrated human subjects.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1998
    Same author

    Inappropriate antidiuresis and hyponatremia with suppressible vasopressin in Guillain-Barré syndrome.

    American journal of nephrology·1998
    Same author

    The role of antiplatelet therapy in stroke prevention.

    Tennessee medicine : journal of the Tennessee Medical Association·1997

    Area of Science:

    • Biochemistry
    • Hematology
    • Cellular Biology

    Background:

    • Platelets play a crucial role in hemostasis and thrombosis.
    • Platelet activation is mediated by various agonists, including platelet-activating factor (PAF).
    • Understanding platelet responsiveness to PAF is vital for comprehending thrombotic disorders.

    Purpose of the Study:

    • To investigate the effect of temperature on human platelet responsiveness to PAF.
    • To elucidate the mechanism of platelet desensitization induced by PAF.

    Main Methods:

    • Human platelets were incubated at different temperatures (25°C and 37°C).
    • Platelet responsiveness to PAF was assessed.
    • Desensitization was induced by pre-exposure to low concentrations of PAF.

    Related Experiment Videos

  • PAF binding affinity and site availability were analyzed.

    • Main Results:

    • Human platelets exhibited reduced responsiveness to PAF at 37°C compared to 25°C.
    • Pre-exposure to low PAF concentrations led to platelet desensitization.
    • Desensitization was associated with a decreased affinity of the high-affinity PAF binding site.
    • Platelet function remained normal for other agonists during PAF desensitization.

    Conclusions:

    • Temperature significantly influences human platelet sensitivity to PAF.
    • PAF-induced platelet desensitization primarily involves altered binding affinity rather than receptor downregulation.
    • These findings contribute to understanding PAF signaling in platelets and potential therapeutic targets.